Heritage
Heritage 
​
Vision, Mission & Values
​
Quality Policy
​
Team
​
​
Foundations
​

Cann Pharmaceutical Australia (CPA) was launched in 2016 - and was the first Australian company to obtain a joint venture with a licensed medicinal cannabis company in Israel - Cann Pharmaceutical Ltd of Israel. CPA was founded with the goal of breaking into the international market for the provision of medicinal cannabis treatments to children with epilepsy.​

​

In Australia, CPA's management, board of directors and advisors consist of proven business, academic and medical leaders with extensive histories of achievement in the medicinal cannabis sector, clinical research, and biotechnology.

​

Collectively, the team's breadth of experience ranges from advanced agribusiness technology, biotechnology, healthcare and the pharmaceutical sectors, plus proven entrepreneurial and business development in Australia and Israel.

​

Certifications

​

CPA's certifications include the issuing of a License for Medicinal Cannabis Cultivation and Production from the Office of Drugs Control (ODC) in 2017, and the issuing of a License for Medicinal Cannabis Manufacturing in 2019.

Cann Pharmaceutical Australia
Level 1
The Realm
18 National Circuit
Barton ACT 2600
​
+61 2 6198 3253
info@cannpharmaceutical.com.au
​
​
  • LinkedIn
  • Facebook
  • Twitter
  • YouTube
Screen Shot 2021-02-08 at 3.34.34 pm cop
Screen Shot 2021-02-08 at 3.43.34 pm cop
The content on this website is not intended as a substitute for professional medical advice and/or as a recommendation and/or approval to use cannabis products, whether they are sold by the company or by another party.
© 2021 Cann Pharmaceutical Australia. All Rights Reserved.